search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


ZOOG MUM


- candidate number21009
- NTR NumberNTR4959
- ISRCTNISRCTN no longer applicable
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR19-nov-2014
- Secondary IDsNL49639 
- Public TitleZOOG MUM
- Scientific TitleDose response of DHA and vitamin supplements during pregnancy and lactation to increase the breast milk DHA content to 0.7-1.0g%
- ACRONYMZOOG MUM
- hypothesis
- Healt Condition(s) or Problem(s) studiedsupplementation of vitamins and fish oil fatty acids, Pregnancy, Breastfeeding
- Inclusion criteriaapparently healthy women, during a non-complicated single pregnancy BMI between 18 and 25 kg/m2 before pregnancy good control of the Dutch language willing to stop taking multivitamins, folic acid, vitamin D and fish oil supplements if taken
- Exclusion criteriahyperemesis graviradum vegetarian or vegan diabetes mellitus criteria for individual ending of the study preterm birth (gestational age less than 37 weeks) and birth after 42 weeks complications mother pregnancy diabetes pre-eclampsia, placental insufficiency, intrauterine growth retardation
- mec approval receivedyes
- multicenter trialno
- randomisedyes
- masking/blindingNone
- controlNot applicable
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-dec-2014
- planned closingdate31-dec-2015
- Target number of participants56
- Interventionsfish oil- fatty acids vitamin D multivitamin
- Primary outcomethe primary aim of the study is to find the dose of DHA during pregnancy and lactation that leads to a mean breast milk DHA of at least 0.7g%
- Secondary outcomeThe secundary aim of the study is to find the dose of vitamin D during pregnancy and lactation that causes a breast milk vitamin D content of 35 nmol/L and increasing breast milk vitamin B1, B2, B12, magnesium, iodide and selenium.
- Timepointsthe first time point is at the start of the study at week 20 in the pregnancy. The second time point (compliance) is week 36 of the pregnancy The third time point and end point is 4 weeks after the delivery
- Trial web site
- statusstopped: trial finished
- CONTACT FOR PUBLIC QUERIES Eline Stoutjesdijk;
- CONTACT for SCIENTIFIC QUERIES Eline Stoutjesdijk;
- Sponsor/Initiator University Medical Center Groningen (UMCG)
- Funding
(Source(s) of Monetary or Material Support)
Ministery of Economic Affairs, Provinces of Drenthe and Province of Groningen, the Netherlands
- Publications
- Brief summary
- Main changes (audit trail)26-jun-2017 MT:
Due to the timings and the deadline for sources of support we included 43 women in the BMI range of 18-29 kg/m2
- RECORD19-nov-2014 - 26-jun-2017


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl